Overview
Derrick Ong practices practicing medicine in Singapore, Singapore.
Their clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Derrick T. Ong
Is Derrick T. Ong a top-rated expert for Glioblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Derrick T. Ong is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Derrick T. Ong participate in research or clinical trials?
Yes. Derrick T. Ong has published 24 articles and abstracts on conditions like Glioblastoma. You can view a list of Derrick T. Ong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaOng isExperienced. Learn about Astrocytoma.
- Brain TumorOng isExperienced. Learn about Brain Tumor.
- GlioblastomaOng isExperienced. Learn about Glioblastoma.
- GliomaOng isExperienced. Learn about Glioma.
- Gliomatosis CerebriOng isExperienced. Learn about Gliomatosis Cerebri.